Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where G A van Seventer is active.

Publication


Featured researches published by G A van Seventer.


Graefes Archive for Clinical and Experimental Ophthalmology | 1999

Human fetal retinal pigment epithelium suppresses the activation of CD4(+) and CD8(+) T-cells.

Lili Farrokh-Siar; Kourous A. Rezai; Roshanak Tolouei Semnani; Samir C. Patel; Jt Ernest; G A van Seventer

Abstract · Background: The suppressive effect of human fetal retinal pigment epithelium (HFRPE) on the activation of human CD4+ and CD8+ T-cells was evaluated in vitro. · Methods: Pure populations of CD4+ and CD8+ T-cells were isolated from human peripheral blood-derived buffy coats by negative immunomagnetic selection. The purity of the cells was examined by flow cytometry using anti-CD3-FITC, anti-CD4-FITC, anti-CD8-PE, and anti-CD20-PE mAbs. HFRPE cells were isolated from fetal eyes and pure cultures were obtained. The effect of normal or IFN-γ-activated HFRPE cells at early (P3) or late (P6) passages on the activation of CD4+ and CD8+ T-cells was assessed in two different T-cell activation assays. In both activation models anti-CD3 mAb (OKT3) provided the antigen-specific signal. The secondary signal for the activation of CD4+ and CD8+ T-cells was provided with anti-CD18 mAb (TS1/18) and anti-CD28 mAb (9.3) in the first and the second assay respectively. Cross-linking of these soluble mAbs was performed with sheep-anti-mouse IgG-coated latex beads. The T-cell activation was determined by cell proliferation measured by [3H]thymidine incorporation. In each activation assay T-cells were incubated with HFRPE cells in a ratio of T-cells to HFRPE of 1:1 or 1:4. · Results: CD4+ and CD8+ T-cells were activated by cross-linking CD3 and CD18 in the first assay (CD3/CD18) and CD3 and CD28 in the second assay (CD3/CD28). In both assays HFRPE inhibited the activation of CD4+ and CD8+ T-cells. IFN-γ-activated HFRPE cells totally suppressed the T-cell activation at a 1:1 ratio. This suppressive effect was weaker at lower cell ratios. Some donor variation was observed in the inhibition at the lower cell ratios, especially for the inhibition of CD8+ T-cell activation with anti-CD3/CD18. The passaging of HFRPE cells did not alter their suppressive effect on CD4+ and CD8+ T-cells. · Conclusions: HFRPE cells suppressed the activation of both CD4+ and CD8+ T-cells in vitro. These findings suggest that RPE-induced immune suppression may play a significant role in maintaining immune privilege in the subretinal space.


Archive | 1989

Down-Regulatory Role of CD8 Molecules in CD2 MAb and CD3 MAb Induced Nonspecific Cytotoxicity of Cytotoxic T Lymphocyte Clones

G A van Seventer; R. A. W. Van Lier; H Spits; Karel C. Kuijpers; Cornelis J. M. Melief

The CD8 (T8) antigen is thought to function as an additional stabilizer of the interaction of the cytotoxic T lymphocyte (CTL) with the target cell by binding to monomorphic determinants on the HLA class I molecules. Recent evidence, however, indicates that the CD8 molecules do not merely serve as passive adhesion structures, but also exert regulating effects on T-cell activity (1). Therefore, we decided to reinvestigate the role of the CD8 antigen in CD8+ HLA class I and class II allospecific human CTL clones.


Journal of Immunology | 1990

The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells.

G A van Seventer; Yoji Shimizu; Kevin J. Horgan; Stephen Shaw


Journal of Immunology | 1990

Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin.

Yoji Shimizu; G A van Seventer; Kevin J. Horgan; Stephen Shaw


Journal of Experimental Medicine | 1992

CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion.

Yoshiya Tanaka; Steven M. Albelda; Kevin J. Horgan; G A van Seventer; Yoji Shimizu; Walter Newman; J Hallam; Peter J. Newman; Clayton A. Buck; Stephen Shaw


Journal of Immunology | 1989

Dual role of the CD44 molecule in T cell adhesion and activation.

Yoji Shimizu; G A van Seventer; R Siraganian; L Wahl; Stephen Shaw


Journal of Immunology | 1994

Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells.

Gerrit Koopman; Robert M. J. Keehnen; Ernst Lindhout; Walter Newman; Yoji Shimizu; G A van Seventer; C.H. de Groot; Steven T. Pals


Science | 1990

LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release

D S A Webb; Yoji Shimizu; G A van Seventer; Stephen Shaw; T L Gerrard


Journal of Experimental Medicine | 1992

Crosslinking of the T cell-specific accessory molecules CD7 and CD28 modulates T cell adhesion.

Yoji Shimizu; G A van Seventer; Elizabeth Ennis; Walter Newman; Kevin J. Horgan; Stephen Shaw


Journal of Immunology | 1989

Two leukocyte receptors (CD11a/CD18 and CD11b/CD18) mediate transient adhesion to endothelium by binding to different ligands.

S K Lo; G A van Seventer; S M Levin; S D Wright

Collaboration


Dive into the G A van Seventer's collaboration.

Top Co-Authors

Avatar

Yoji Shimizu

University of Minnesota

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kevin J. Horgan

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Walter Newman

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

A Kopelan

University of Chicago

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge